← Back to all articles
ReviewsPubMed VerifiedOpen Access

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and LSD: a systematic review of clinical trials published in the last 25 years

Dos Santos RG, Osorio FL, Crippa JAS, Riba J, Zuardi AW, Hallak JEC

Therapeutic Advances in Psychopharmacology (2016)

Systematic review
Abstract

Systematic review of clinical trials (1990-2015) of ayahuasca, psilocybin, and LSD for depression, anxiety, and addiction. Found beneficial effects for treatment-resistant depression, illness-related anxiety, and substance dependence.

Citations350
Study TypeSystematic review
systematic reviewclinical trialspsychedelicsdepressionaddiction
DOI: 10.1177/2045125316638008View on PubMed

Related Articles

Reviews

The effects of ayahuasca on psychological disorders: a systematic literature review

Sheth R, Parikh E et al.

Cureus, 2024
Reviews

Ayahuasca's therapeutic potential: What we know - and what not

Maia LO, Daldegan-Bueno D et al.

European Neuropsychopharmacology, 2023
Reviews

Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies

Dos Santos RG, Hallak JEC

Journal of Psychoactive Drugs, 2021
Reviews

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

Romeo B, Karila L et al.

Psychopharmacology, 2020